Daphne Karydas Mineralys Therapeutics, Inc. (MLYS) insider trading activity

MLYS Quotes by TradingView
Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held N/A

Daphne Karydas Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 13 2025
SELL
Open market or private sale
$691,350 $46.09 p/Share
15,000 Reduced 100.0%
0 Common Stock
Nov 13 2025
BUY
Exercise of conversion of derivative security
$153,000 $10.2 p/Share
15,000 Added 50.0%
15,000 Common Stock

Also insider at

LOGC
LogicBio Therapeutics, Inc. Healthcare
Director
SNDX
Syndax Pharmaceuticals Inc Healthcare
Chief Financial Officer
CMPS
COMPASS Pathways plc Healthcare
Director
DK

Daphne Karydas

Director
Lexington, MA

Track Institutional and Insider Activities on MLYS

Follow Mineralys Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MLYS shares.

Notify only if

Insider Trading

Get notified when an Mineralys Therapeutics, Inc. insider buys or sells MLYS shares.

Notify only if

News

Receive news related to Mineralys Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MLYS